Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver or gastrointestinal diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and preclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts, and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008. The Boston Business Journal named Albireo one of the 2019 Best Places to Work in Massachusetts.
When did they start Albireo Pharma, Inc.?
Benjamin Gardner3 years ago
In 2008, I believe.